Residual risk in dyslipidaemias: from statins to PCSK9 inhibitors and beyond.

29 August 2022 (14:00 - 14:15)
Organised by:
Congress Presentation Part of: How to deal with residual cardiovascular risk in atherosclerotic disease? New pharmacotherapeutic options Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2022